BRIEF-Brooklyn Immunotherapeutics Announces Name Change To Eterna Therapeutics

Reuters2022-10-11

Oct 11 (Reuters) - Brooklyn Immunotherapeutics Inc

:

* BROOKLYN IMMUNOTHERAPEUTICS ANNOUNCES NAME CHANGE TO ETERNA THERAPEUTICS AND PROVIDES CORPORATE UPDATES

* THE NAME CHANGE WILL BE EFFECTIVE MONDAY, OCTOBER 17, 2022

* CO’S COMMON STOCK WILL TRADE ON THE NASDAQ GLOBAL MARKET UNDER THE NEW TICKER SYMBOL “ERNA”

* A ONE-FOR-TWENTY CONSOLIDATION OF CO’S COMMON STOCK, WILL BECOME EFFECTIVE AT OPEN OF THE MARKET ON OCT 17

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment